Lexicon Pharmaceuticals
LXRX
#6626
Rank
A$1.21 B
Marketcap
A$2.72
Share price
-2.02%
Change (1 day)
62.10%
Change (1 year)

P/S ratio for Lexicon Pharmaceuticals (LXRX)

P/S ratio as of September 2026 (TTM): 12.7

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.34. At the end of 2026 the company had a P/S ratio of 10.0.

P/S ratio history for Lexicon Pharmaceuticals from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202610.020.67%
20258.32-7.52%
20249.00-97.11%
2023311-88.01%
2022> 100031.73%
2021> 10009661.37%
202020.21372.78%
20191.37-87.63%
201811.1-4.13%
201711.5-33.11%
201617.362.75%
201510.6-63.22%
201428.8-93.06%
2013416-60.01%
2012> 1000341.36%
2011236137.98%
201099.0254.62%
200927.9371.12%
20085.93-28.35%
20078.27114.35%
20063.8623.92%
20053.11-60.96%
20047.97-7.68%
20038.6422.76%
20027.04258.18%
20011.96

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Thermo Fisher Scientific
TMO
5.02-60.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
7.16-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.48-56.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
2.00-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
20.4 61.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.96-84.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
3.52-72.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.96-68.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA